Check our
Open Access Repository.
2024
169 publication(s):Note: when necessary, only the first 5 authors are displayed.Articles
- 81 -
-
How can the environmental sustainability of healthcare products be taken into account throughout their life cycle?
- Bruno Laviolle, Pierre-Frédéric Degon, Cécile Gillet Giraud, Dominique Thiveaud, Philippe Lechat et al.
- Therapies, 2024, 79 (1), pp.61-74.
- DOI : https://doi.org/10.1016/j.therap.2023.12.001
- Pubmed : 38102030
-
-
- 82 -
-
Le groupe FRANCOGYN : bilan et avenir
FRANCOGYN group: A brief history
- Vincent Lavoué, Emilie Raimond, Marcos Ballester, Xavier Carcopino, Henri Azaïs et al.
- Le groupe FRANCOGYN : bilan et avenir. Gynecologie, Obstetrique, Fertilite and Senologie, 2024, 52 (1), pp.51-54.
- DOI : https://doi.org/10.1016/j.gofs.2023.10.005
- Pubmed : 37839793
-
-
- 83 -
-
Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndrome
- Hortense Lecoeuvre, Franҫois Le Gall, Cécile Le Naoures Mear, Marie Dominique Vignon-Pennamen, Claire Lamaison et al.
- Clinical and Experimental Dermatology, 2024, Clinical and Experimental Dermatology,
- DOI : https://doi.org/10.1093/ced/llae015
- Pubmed : 38366665
-
-
- 84 -
-
Isotrétinoïne : quelles actualités en dermatologie ? Conclusions du séminaire Centre de preuves en dermatologie et groupe DEFI de la SFD
Isotretinoin: What's new in dermatology? Conclusions from the workshop organized by the Centre of Evidence of the French Society of Dermatology and the French Facial Dermatosis Group (groupe DEFI)
- S Leducq, Florence Poizeau, G. Chaby, J. Tannous, F. Ballanger-Desolneux et al.
- Isotrétinoïne : quelles actualités en dermatologie ? Conclusions du séminaire Centre de preuves en dermatologie et groupe DEFI de la SFD. Annales de Dermatologie et de Vénéréologie - FMC, 2024, Annales de Dermatologie et de Vénéréologie - F-C, 4 (2), pp.144-154.
- DOI : https://doi.org/10.1016/j.fander.2023.06.005
-
-
- 85 -
-
Assessing the contribution of the chemical exposome to neurodegenerative disease
- S. Lefevre-Arbogast, Jade Chaker, Fabien Mercier, Robert Barouki, Xavier Coumoul et al.
- Nature Neuroscience, 2024, 27, p. 812-821.
- DOI : https://doi.org/10.1038/s41593-024-01627-1
- Pubmed : 38684891
-
-
- 86 -
-
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1 infected-patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER Study)
- Florian Lemaitre, Jennifer Lagoutte-Renosi, Marie-Claude Gagnieu, François Parant, Nicolas Venisse et al.
- British Journal of Clinical Pharmacology, 2024, 90 (1), pp.264-273.
- DOI : https://doi.org/10.1111/bcp.15890
- Pubmed : 37602480
-
-
- 87 -
-
Harmonized quality assurance/quality control provisions to assess completeness and robustness of MS1 data preprocessing for LC-HRMS-based suspect screening and non-targeted analysis
- Sarah Lennon, Jade Chaker, Elliott Price, Juliane Hollender, Carolin Huber et al.
- Trends in Analytical Chemistry, 2024, 174, pp.117674.
- DOI : https://doi.org/10.1016/j.trac.2024.117674
-
-
- 88 -
-
Systemic sclerosis, silica exposure and cellular therapies: The sand in the gears?
- A Lescoat, D Rimar, D Farge
- La Revue de Médecine Interne, 2024, La Revue de Medecine Interne,
- DOI : https://doi.org/10.1016/j.revmed.2024.02.003
- Pubmed : 38395716
-
-
- 89 -
-
Pre-scleroderma and new opportunities for preventive medicine – Authors’ reply
- Alain Lescoat, Dinesh Khanna, Masataka Kuwana, Yannick Allanore, Marco Matucci-Cerinic et al.
- The Lancet Rheumatology, 2024, 6 (4), pp.e201.
- DOI : https://doi.org/10.1016/s2665-9913(24)00058-4
-
-
- 90 -
-
Comité de surveillance indépendant dans les essais cliniques : de la justification scientifique à l’organisation
- Clara Locher, Silvy Laporte, Peggy Derambure, Olivier Chassany, Cécile Girault et al.
- Therapies, 2024, 79 (1), pp.99-110.
- DOI : https://doi.org/10.1016/j.therap.2023.10.013
- Pubmed : 37985309
-
-